Phase I abuse liability trial of intranasally administered benzhydrocodone/paracetamol (KP 201), compared with hydrocodone/paracetamol.
Phase of Trial: Phase I
Latest Information Update: 09 Sep 2016
At a glance
- Drugs Benzhydrocodone/paracetamol (Primary) ; Hydrocodone/paracetamol
- Indications Pain
- Focus Adverse reactions
- Sponsors KemPharm
- 09 Sep 2016 According to a KemPharm media release, the results will be presented at the annual meeting PAINWeek 2016.
- 08 Sep 2016 Results published in a KemPharm media release.
- 06 Jun 2016 Data will be presented at the 2016 International Conference on Opioids (ICOO), according to a KemPharm media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History